Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection
Atsufumi Kawabata, … , Yasuo Oda, Kazuaki Kakehi
Atsufumi Kawabata, … , Yasuo Oda, Kazuaki Kakehi
Published June 1, 2001
Citation Information: J Clin Invest. 2001;107(11):1443-1450. https://doi.org/10.1172/JCI10806.
View: Text | PDF
Article Article has an altmetric score of 3

The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection

  • Text
  • PDF
Abstract

Protease-activated receptor-2 (PAR-2), a receptor activated by trypsin/tryptase, modulates smooth muscle tone and exocrine secretion in the salivary glands and pancreas. Given that PAR-2 is expressed throughout the gastrointestinal tract, we investigated effects of PAR-2 agonists on mucus secretion and gastric mucosal injury in the rat. PAR-2–activating peptides triggered secretion of mucus in the stomach, but not in the duodenum. This mucus secretion was abolished by pretreatment with capsaicin, which stimulates and ablates specific sensory neurons, but it was resistant to cyclo-oxygenase inhibition. In contrast, capsaicin treatment failed to block PAR-2–mediated secretion from the salivary glands. Intravenous calcitonin gene–related peptide (CGRP) and neurokinin A markedly elicited gastric mucus secretion, as did substance P to a lesser extent. Specific antagonists of the CGRP1 and NK2, but not the NK1, receptors inhibited PAR-2–mediated mucus secretion. Pretreatment with the PAR-2 agonist strongly prevented gastric injury caused by HCl-ethanol or indomethacin. Thus, PAR-2 activation triggers the cytoprotective secretion of gastric mucus by stimulating the release of CGRP and tachykinins from sensory neurons. In contrast, the PAR-2–mediated salivary exocrine secretion appears to be independent of capsaicin-sensitive sensory neurons.

Authors

Atsufumi Kawabata, Mitsuhiro Kinoshita, Hiroyuki Nishikawa, Ryotaro Kuroda, Minoru Nishida, Hiromasa Araki, Naoki Arizono, Yasuo Oda, Kazuaki Kakehi

×

Total citations by year

Year: 2024 2023 2021 2020 2019 2018 2014 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 Total
Citations: 1 1 2 1 3 1 1 2 2 3 2 3 2 3 8 1 1 1 38
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (38)

Title and authors Publication Year
A novel trypsin of Trichinella spiralis mediates larval invasion of gut epithelium via binding to PAR2 and activating ERK1/2 pathway
Han LL, Lu QQ, Zheng WW, Li YL, Song YY, Zhang XZ, Long SR, Liu RD, Wang ZQ, Cui J
PLoS neglected tropical diseases 2024
Topographical distribution and morphology of SP-IR axons in the antrum, pylorus, and duodenum of mice
Mistareehi A, Bendowski KT, Bizanti A, Madas J, Zhang Y, Kwiat AM, Nguyen D, Kogut N, Ma J, Chen J, Cheng Z(
Autonomic neuroscience : basic & clinical 2023
Neuro-innate immune interactions in gut mucosal immunity
S Kulkarni, S Kurapati, M Bogunovic
Current Opinion in Immunology 2021
Proteolytic activity of Triatoma infestans saliva associated with PAR-2 activation and vasodilation
KA Oliveira, RJ Torquato, DC Lustosa, T Ribeiro, BW Nascimento, LC de Oliveira, MA Juliano, T Paschoalin, VS Lemos, RN Araujo, MH Pereira, AS Tanaka
Journal of Venomous Animals and Toxins 2021
The Immature Gut Barrier and Its Importance in Establishing Immunity in Newborn Mammals
B Weström, EA Sureda, K Pierzynowska, SG Pierzynowski, FJ Pérez-Cano
Frontiers in immunology 2020
Preventive Effect of Lactobacillus fermentum CQPC08 on 4-Nitroquineline-1-Oxide Induced Tongue Cancer in C57BL/6 Mice
B Liu, J Zhang, R Yi, X Zhou, X Long, Y Pan, X Zhao
Foods 2019
Small Intestine Protection of Mica Against Non-Steroidal Anti-Inflammatory Drugs-Injury Through ERK1/2 Signal Pathway in Rats
S Zhang, Y He, Z Shi, J Jiang, B He, S Xu, Z Fang
Frontiers in pharmacology 2019
Bioengineered in vitro enteric nervous system
E Manousiouthakis, Y Chen, DM Cairns, R Pollard, K Gerlovin, MJ Dente, Y Razavi, DL Kaplan
Journal of Tissue Engineering and Regenerative Medicine 2019
Preventive Effect of Raw Liubao Tea Polyphenols on Mouse Gastric Injuries Induced by HCl/Ethanol via Anti-Oxidative Stress
Y Qian, J Zhang, X Fu, R Yi, P Sun, M Zou, X Long, X Zhao
Molecules (Basel, Switzerland) 2018
Proteinase activated-receptors-associated signaling in the control of gastric cancer
S Sedda
World journal of gastroenterology : WJG 2014
Protease activated receptor-2 mediates activated protein C-induced cutaneous wound healing via inhibition of p38
SM Julovi, M Xue, S Dervish, PN Sambrook, L March, CJ Jackson
The American Journal of Pathology 2011
Proteinase-activated Receptor 2 Activation Promotes an Anti-inflammatory and Alternatively Activated Phenotype in LPS-stimulated Murine Macrophages
QM Nhu, KA Shirey, ME Pennini, J Stiltz, SN Vogel
Innate immunity 2011
Receptor-promoted exocytosis of airway epithelial mucin granules containing a spectrum of adenine nucleotides
SM Kreda, L Seminario-Vidal, CA van Heusden, W O'Neal, L Jones, RC Boucher, ER Lazarowski
The Journal of Physiology 2010
Contribution of bone marrow-derived cells to the pro-inflammatory effects of protease-activated receptor-2 in colitis
E Hyun, P Andrade-Gordon, M Steinhoff, PL Beck, N Vergnolle
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2010
Over-expression and localization of a host protein on the membrane of Cryptosporidium parvum infected epithelial cells
YL Yang, MG Serrano, AS Sheoran, PA Manque, GA Buck, G Widmer
Molecular and Biochemical Parasitology 2009
Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo
QM Nhu, K Shirey, JR Teijaro, DL Farber, S Netzel-Arnett, TM Antalis, A Fasano, SN Vogel
Mucosal Immunology 2009
Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo
T Kanke, M Kabeya, S Kubo, S Kondo, K Yasuoka, J Tagashira, H Ishiwata, M Saka, T Furuyama, T Nishiyama, T Doi, Y Hattori, A Kawabata, MR Cunningham, R Plevin
British Journal of Pharmacology 2009
Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more
R Ramachandran, MD Hollenberg
British Journal of Pharmacology 2008
Gastrointestinal roles for proteinase-activated receptors in health and disease
A Kawabata, M Matsunami, F Sekiguchi
British Journal of Pharmacology 2008
Sensitization of TRPA1 by PAR-2 through PLC/PIP2-dependent mechanisms contributes to inflammatory pain
Yi Dai, Shenglan Wang, Makoto Tominaga, Satoshi Yamamoto, Tetsuo Fukuoka, Tomohiro Higashi, Kimiko Kobayashi, Koichi Obata, Hiroki Yamanaka, Koichi Noguchi
Journal of Clinical Investigation 2007
Protease-activated receptor-2 (PAR-2) is a weak enhancer of mucin secretion by human bronchial epithelial cells in vitro
KW Lin, J Park, AL Crews, Y Li, KB Adler
The International Journal of Biochemistry & Cell Biology 2007
The emergence of proteinase-activated receptor-2 as a novel target for the treatment of inflammation-related CNS disorders: PAR-2 as a novel target in inflammation-related CNS disorders
T Bushell
The Journal of Physiology 2007
Suppression of pancreatitis-related allodynia/hyperalgesia by proteinase-activated receptor-2 in mice
A Kawabata, M Matsunami, M Tsutsumi, T Ishiki, O Fukushima, F Sekiguchi, N Kawao, T Minami, T Kanke, N Saito
British Journal of Pharmacology 2006
Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cɛ- and A-dependent mechanisms in rats and mice: PAR 2 -mediated TRPV1 sensitization
S Amadesi, GS Cottrell, L Divino, K Chapman, EF Grady, F Bautista, R Karanjia, C Barajas-Lopez, S Vanner, N Vergnolle, NW Bunnett
The Journal of Physiology 2006
2-Furoyl-LIGRL-NH2, a potent agonist for proteinase-activated receptor-2, as a gastric mucosal cytoprotective agent in mice
A Kawabata, Y Oono, D Yonezawa, K Hiramatsu, N Inoi, F Sekiguchi, M Honjo, M Hirofuchi, T Kanke, H Ishiwata
British Journal of Pharmacology 2005
Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2
T Kanke, H Ishiwata, M Kabeya, M Saka, T Doi, Y Hattori, A Kawabata, R Plevin
British Journal of Pharmacology 2005
Protease-Activated Receptors: Regulation of Neuronal Function
T Saito, NW Bunnett
NeuroMolecular Medicine 2005
Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain
Y Dai, T Moriyama, T Higashi, K Togashi, K Kobayashi, H Yamanaka, M Tominaga, K Noguchi
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004
Modulation of visceral pain and inflammation by protease-activated receptors
N Vergnolle
British Journal of Pharmacology 2004
Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome
A Lecci, A Capriati, CA Maggi
British Journal of Pharmacology 2004
Protease-Activated Receptor 2 Sensitizes the Capsaicin Receptor Transient Receptor Potential Vanilloid Receptor 1 to Induce Hyperalgesia
S Amadesi
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004
Protease activated receptors in cardiovascular function and disease
JA Barnes, S Singh, AV Gomes
Molecular and Cellular Biochemistry 2004
Do Salivary Proline-Rich Proteins Counteract Dietary Hydrolyzable Tannin in Laboratory Rats?
MM Skopec, AE Hagerman, WH Karasov
Journal of Chemical Ecology 2004
Progress in the Understanding of Protease-Activated Receptors
EC Gabazza, O Taguchi, H Kamada, T Hayashi, Y Adachi, K Suzuki
International Journal of Hematology 2004
Activation of human colon mast cells through proteinase activated receptor-2
He SH, He YS, Xie H
World Journal of Gastroenterology 2004
Involvement of EDHF in the hypotension and increased gastric mucosal blood flow caused by PAR-2 activation in rats
A Kawabata, Y Nakaya, R Kuroda, M Wakisaka, T Masuko, H Nishikawa, K Kawai
British Journal of Pharmacology 2003
Protease-activated receptor-2 (PAR-2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretion
N Kawao, Y Sakaguchi, A Tagome, R Kuroda, S Nishida, K Irimajiri, H Nishikawa, K Kawai, MD Hollenberg, A Kawabata
British Journal of Pharmacology 2002
Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis
S Fiorucci, A Mencarelli, B Palazzetti, E Distrutti, N Vergnolle, MD Hollenberg, JL Wallace, A Morelli, G Cirino
Proceedings of the National Academy of Sciences 2001

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
42 readers on Mendeley
See more details